Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Market share of the generic pharmaceuticals in Norway 2000-2017

Market share of generic pharmaceuticals in Norway from 2000 to 2017

by F. Norrestad, last edited Aug 9, 2019
Market share of the generic pharmaceuticals in Norway 2000-2017 The market for copied brand-named drugs, the so-called generic pharmaceuticals, has been increasing in Norway for years. In 2017, generic pharmaceuticals composed 49.1 percent of the total pharmaceutical market volume in the country. The turnover share from the generic pharmaceuticals has also been increasing over the years and reached half of the turnover from total pharmaceutical sales in Norway in 2017.
 Large share of expired patents

  A generic drug contains the same chemical substance as an original, previously patented, brand-named drug, and can enter the market first when the patent of the original drug has expired. In 2016, the largest share of the pharmaceutical sales in Norway came from drugs whose patents were expired, and a large part even from drugs whose patent expired 40 years ago or longer.

The whole pharmaceutical market in Norway is growing 

  The sales value of the total pharmaceutical market has been increasing since 2000. In 2017, the market reached the highest sales value, amounting to almost 27 billion Norwegian kroner.
Show more

Market share of generic pharmaceuticals in Norway from 2000 to 2017

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Generics and biosimilars in Italy"
  • Global overview
The most important statistics
  • Italy: pharmaceutical market and industry
  • Biosimilar drugs
  • Generic drugs
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.